Literature DB >> 16460449

Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques.

P Rossignol1, A Luttun, J L Martin-Ventura, F Lupu, P Carmeliet, D Collen, E Anglès-Cano, H R Lijnen.   

Abstract

BACKGROUND: Apoptosis of vascular cells is considered to be a major determinant of atherosclerotic plaque vulnerability and potential rupture. Plasmin can be generated in atherosclerotic plaques and recent in vitro data suggest that plasminogen activation may trigger vascular smooth muscle cell (VSMC) apoptosis. AIM: To determine whether plasminogen activation may induce aortic VSMC apoptosis ex vivo and in vivo. METHODS AND
RESULTS: Mice with single or combined deficiencies of apolipoprotein E (ApoE) and plasminogen activator inhibitor-1 (PAI-1) were used. Ex vivo incubation with plasminogen of isolated aortic tunica media from PAI-1-deficient mice induced plasminogen activation and VSMC apoptosis, which was inhibited by alpha2-antiplasmin. In vivo, levels of plasmin, active caspase 3 and VSMC apoptotic index were significantly higher in atherosclerotic aortas from mice with combined ApoE and PAI-1 deficiencies than in those from littermates with single ApoE deficiency. A parallel decrease in VSMC density was observed.
CONCLUSIONS: These data strongly suggest that plasminogen activation may contribute to VSMC apoptosis in atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460449      PMCID: PMC2244648          DOI: 10.1111/j.1538-7836.2005.01765.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  45 in total

Review 1.  Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.

Authors:  P Carmeliet; L Moons; M Dewerchin; N Mackman; T Luther; G Breier; V Ploplis; M Müller; A Nagy; E Plow; R Gerard; T Edgington; W Risau; D Collen
Journal:  Ann N Y Acad Sci       Date:  1997-04-15       Impact factor: 5.691

2.  Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.

Authors:  H R Lijnen; K Okada; O Matsuo; D Collen; M Dewerchin
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

3.  Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions.

Authors:  J J Boyle; D E Bowyer; P L Weissberg; M R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

4.  Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells.

Authors:  K Hishikawa; T Nakaki; T Fujii
Journal:  Eur J Pharmacol       Date:  1999-12-03       Impact factor: 4.432

5.  Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Eur J Biochem       Date:  1996-11-01

6.  Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes.

Authors:  A A Stoop; F Lupu; H Pannekoek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

7.  Apoptosis and related proteins in different stages of human atherosclerotic plaques.

Authors:  M M Kockx; G R De Meyer; J Muhring; W Jacob; H Bult; A G Herman
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

8.  Plasminogen activator system in human coronary atherosclerosis.

Authors:  P N Raghunath; J E Tomaszewski; S T Brady; R J Caron; S S Okada; E S Barnathan
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-09       Impact factor: 8.311

9.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

Authors:  Y J Geng; P Libby
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

10.  Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis.

Authors:  H C Kwaan; J Wang; K Svoboda; P J Declerck
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  15 in total

Review 1.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

2.  PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.

Authors:  Monica Mariana Baluta; Marius Marcian Vintila
Journal:  Maedica (Buchar)       Date:  2015-06

3.  Plasmin on adherent cells: from microvesiculation to apoptosis.

Authors:  Loïc Doeuvre; Laurent Plawinski; Didier Goux; Denis Vivien; Eduardo Anglés-Cano
Journal:  Biochem J       Date:  2010-12-01       Impact factor: 3.857

4.  Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis.

Authors:  Patrick Rossignol; Eduardo Anglès-Cano; Henri Roger Lijnen
Journal:  Thromb Haemost       Date:  2006-11       Impact factor: 5.249

5.  Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants.

Authors:  A K M Tarikuz Zaman; Satoshi Fujii; David J Schneider; Douglas J Taatjes; H Roger Lijnen; Burton E Sobel
Journal:  Histochem Cell Biol       Date:  2007-06-19       Impact factor: 4.304

6.  Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension.

Authors:  Carlos Zamarrón; Jorge Ricoy; Alberto Riveiro; Francisco Gude
Journal:  Lung       Date:  2008-03-11       Impact factor: 2.584

Review 7.  Plasminogen activator inhibitor-1: the double-edged sword in apoptosis.

Authors:  Rashna D Balsara; Victoria A Ploplis
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

Review 8.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

9.  Patterns of kinase activation induced by injury in the murine femoral artery.

Authors:  Yiping Zou; Yan Qi; Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07-13       Impact factor: 2.192

10.  Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.

Authors:  Romaric Lacroix; Florence Sabatier; Agnès Mialhe; Agnès Basire; Ralph Pannell; Hélène Borghi; Stephane Robert; Edouard Lamy; Laurent Plawinski; Laurence Camoin-Jau; Victor Gurewich; Eduardo Angles-Cano; Françoise Dignat-George
Journal:  Blood       Date:  2007-07-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.